Cost-effectiveness of folfirinox for first-line treatment of metastatic pancreatic cancer

BACKGROUND: The accord 11/0402 trial demonstrated that folfirinox (5-fluorouracil, leucovorin, irinotecan, oxaliplatin) is significantly more efficacious than gemcitabine monotherapy in the first-line treatment of metastatic pancreatic cancer (mpc). The present study assessed the cost-effectiveness...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Attard, C.L., Brown, S., Alloul, K., Moore, M.J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Multimed Inc. 2014
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3921047/
https://ncbi.nlm.nih.gov/pubmed/24523620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.21.1327
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller